Literature DB >> 8864138

Role of interferon-gamma in immunity to herpes simplex virus.

Z Yu1, E Manickan, B T Rouse.   

Abstract

Removal of herpes simplex virus (HSV)-infected cells from peripheral sites such as the skin is mainly an activity of T cells, particularly the CD4+ T subset. Such cells orchestrate an inflammatory response with interferon-gamma (IFN-gamma) appearing to play the essential role in viral clearance. In accordance with this hypothesis, we show that infection of BALB/c background mice expressing the knockout phenotype for IFN-gamma (GKO mice) are significantly more susceptible to the development of cutaneous zosteriform lesions than are wild-type. However, following HSV immunization, GKO mice become solidly immune to the development of zosteriform lesions. In addition, the transfer of T cells from immune GKO mice to nude mice recipients renders them resistant to zosteriform lesions. Our results are discussed in terms of the major and compensatory mechanisms available to the body to effect immunity to viral infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864138     DOI: 10.1002/jlb.60.4.528

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  24 in total

1.  CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma.

Authors:  J P Christensen; R D Cardin; K C Branum; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  T helper 1-type cytokine transcription in peripheral blood mononuclear cells of pseudorabies virus (Suid herpesvirus 1)-primed swine indicates efficient immunization.

Authors:  T Fischer; M Büttner; H J Rziha
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

3.  Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon.

Authors:  Melanie D Bird; Chin-Fun Chu; Alison J Johnson; Gregg N Milligan
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

Review 4.  BHV-1: new molecular approaches to control a common and widespread infection.

Authors:  L Turin; S Russo; G Poli
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

Review 5.  Dissecting the host response to a gamma-herpesvirus.

Authors:  P C Doherty; J P Christensen; G T Belz; P G Stevenson; M Y Sangster
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

6.  Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology.

Authors:  Amol Suryawanshi; Tamara Veiga-Parga; Naveen K Rajasagi; Pradeep Babu Jagdeesh Reddy; Sharvan Sehrawat; Shalini Sharma; Barry T Rouse
Journal:  J Immunol       Date:  2011-07-15       Impact factor: 5.422

7.  Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.

Authors:  Melanie E Dobbs; Jane E Strasser; Chin-Fun Chu; Claudia Chalk; Gregg N Milligan
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection.

Authors:  A X Holterman; K Rogers; K Edelmann; D M Koelle; L Corey; C B Wilson
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection.

Authors:  Alison J Johnson; Michelle H Nelson; Melanie D Bird; Chin-Fun Chu; Gregg N Milligan
Journal:  J Reprod Immunol       Date:  2009-11-25       Impact factor: 4.054

10.  Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.

Authors:  S E Dorman; S M Holland
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.